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Abstract
Human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are important respiratory pathogens of small children
and adults. The present study aimed to design a sensitive real-time RT-PCR assay for the detection of hRSV and hMPV in comparison
with direct ﬂuorescent assay (DFA) and to determine the incidence of hMPV and hRSV as causative agents of respiratory infections in a
Finnish population. For DFA detection of hMPV antigen, four commercial antibodies were evaluated. The duplex real-time RT-PCR
assay achieved a sensitivity of 103 copies/mL of specimen for hRSV and hMPV type A viruses and 104 copies/mL for type B hMPV. The
detection rate of the RT-PCR assay was compared with those for DFA detection of hMPV and hRSV in analyses of 350 nasopharyngeal
aspirates sent to HUSLAB, Helsinki University Hospital, for routine virus diagnostics during November 2007 to June 2008. Of the sam-
ples analyzed, 43 (12.3%) were positive for hRSV by DFA and an additional 13 specimens (3.7%) were positive for hRSV by RT-PCR.
Only four samples (1.1 %) were found to be positive for hMPV RNA by RT-PCR, with two of them also positive by DFA. The duplex
real-time RT-PCR assay described in the present study can therefore be applied for efﬁcient identiﬁcation of hMPV and hRSV in clinical
specimens and collection of information on the epidemiology and clinical outcome of these viruses.
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Introduction
Human respiratory syncytial virus (hRSV) and human meta-
pneumovirus (hMPV) are known as respiratory pathogens of
small children. However, recent studies provide increasing
evidence that hRSV and hMPV also cause a wide spectrum of
respiratory symptoms in adults [1–4].
Diagnosis of hRSV is commonly based on antigen detec-
tion using commercially available point-of-care tests and
direct ﬂuorescence assay (DFA). For hMPV detection, the
traditional virus isolation in cell culture is trypsin-dependent
and requires long incubation times, and untypical cell lines
[5]. Furthermore, antibody responses have not been useful
in the diagnostics of acute hMPV infections [6]. Recently,
commercial monoclonal antibodies for detection of hMPV
antigens in clinical samples have become available, promoting
the rapid detection of the virus [7–9]. Limitations of the tra-
ditional culture-based diagnostics and increasing knowledge
of the genetics of hRSV and hMPV have led to development
of a number of real-time RT-PCR-based assays enabling rapid
and speciﬁc detection of the viruses in clinical specimens
[10–13].
Overlapping seasonal occurrence of hRSV and hMPV with
other respiratory viruses [3,4,14–16] and the inability to clin-
ically distinguish between hRSV and hMPV infections or ill-
nesses seen with other respiratory viruses [2,4,15–18]
emphasize the need for a sensitive and rapid detection of
these viruses. We describe a duplex real-time RT-PCR assay
for simultaneous detection of hMPV and hRSV in clinical
samples. In addition, data from an evaluation of four com-
mercially available monoclonal antibodies for DFA detection
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of hMPV in clinical samples is presented in comparison with
the real-time RT-PCR assay.
Materials and Methods
Clinical samples and quality controls
Of the clinical specimens sent to HUSLAB, Helsinki Univer-
sity Hospital, for DFA detection of adenovirus, inﬂuenza A
and B viruses, hRSV and parainﬂuenza viruses 1–3 during a
period of November 2007 to June 2008, 24 bronchoalveolar
lavage (BAL) samples and 326 nasopharyngeal aspirates
(NPAs) were available for the present study. Samples origi-
nated from both immunocompetent and immunocompro-
mised patients. Of the 350 samples analyzed, 148 (42.3%)
were from patients aged less than 3 years, 102 (29.1%) from
those aged 3–18 years and 100 (28.6%) from those over
18 years of age. Also examined were 24 quality assurance
samples from the 2006 and 2007 Metapneumovirus & Respi-
ratory Syncytial virus RNA Proﬁciency Programmes (QCMD,
Glasgow, UK), ﬁve quality control samples containing adeno-
viruses 4, 5 and 7 from the 2006 Adenovirus Programme
and three samples containing echoviruses 16 and 30 and cox-
sackievirus B3 from the 2006 Enterovirus Programme of the
same organizer. Nucleic acids from all samples were isolated
by QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA, USA)
and RNAs were instantly subjected to duplex RT-PCR assay.
Production of viral RNAs
The hRSV strain B/Wash/18537/’62 (CH18537) (ATCC No.
VR-1401) was obtained from the American Type Culture
Collection (Manassas, VA, USA). The hMPV type B1 (strain
NL/1/99) and type A1 (strain NL/1/00) were obtained as
quality control samples from QCMD.
For production of viral RNAs, the viral templates were
ampliﬁed in an RT-PCR reaction using primers RSV-CF, RSV-
CR, MPV-CF and MPV-CR as described in Table 1 and tran-
scribed with T3 RNA polymerase (AmpliScribe T3-Flash
Transcription Kit; Epicentre Biotechnologies, Madison, WI,
USA) in accordance with the manufacturer’s instructions.
The RT-PCR amplicons were degraded in DNase incubation
(Turbo DNA-free Kit; Ambion, Austin, TX, USA) and the
RNAs puriﬁed with RNeasy Mini Kit (Qiagen) and analyzed
by agarose gel electrophoresis. The RNA concentrations
were determined by measuring optical density at 260 nm
using NanoDrop ND-1000 UV-Vis Spectrophotometer
(NanoDrop Technologies Inc., Wilmington, DE, USA).
Real-time RT-PCR
Two primer sets from the nucleoprotein genes of hRSV (prim-
ers RSV-F and RSV-R) and hMPV (primers MPV-F and MPV-R)
were designed (Table 1). The reaction mixture for separate
RT-PCR reactions consisted of 300 lM dNTPs (600 lM for
dUTP), 50 mM Bicine, 115 mM KAc, 0.01 mM EDTA, 60 nM
Rox, 3.0 mM MnAc, 5 U rTth DNA polymerase and 0.5 U
uracil N-glycosylase in a total volume of 50 ll (TaqMan EZ
RT-PCR Kit; Applied Biosystems, Foster City, CA, USA). For
the duplex RT-PCR, increased concentrations of 4.5 mM
MnAc and 2 U of Ampli Taq Gold polymerase (Roche Diag-
nostics, Basel, Switzerland) were used. A concentration of
500 nM was used for primers RSV-F, RSV-R and MPV-R, and
700 nM for hMPV-F. The optimal concentrations for combined
MPV-A and MPV-B probes and RSV-probe were 100 nM and
150 nM, respectively. Ten microlitre of the viral template was
used in a total volume of 50 lL RT-PCR reaction.
Ampliﬁcation was performed on a Stratagene MXP3000 in
duplicate (Stratagene, La Jolla, CA, USA). An UNG-treatment
of 2 min at 50C was followed by RT-reaction at 60C for
40 min and inactivation of UNG at 95C for 5 min. The
cycling conditions were: denaturation at 94C for 20 s and
annealing and extension at 60C for 60 s. These steps were
repeated 45 times.
TABLE 1. Primers and probes used for production of viral RNAs and RT-PCR ampliﬁcation
Virus genus and target gene Oligonucleotide designation Sequence (5¢ to 3¢) and orientationa
hRSV, nucleoprotein Primer RSV-CFb GATGGGGCAAATATGGAAACA, +
Primer RSV-CR GATTGCAAATCGTGTAGCTGT, )
Primer RSV-F TGGAAACATACGTGAACAARCTTCA, +
Primer RSV-R GCACCCATATTGTWAGTGATGCA, )
Probe RSV HEX-CGAAGGCTCCACATACACAGCWGCTGT-BHQ, +
hMPV, nucleoprotein Primer MPV-CFb AATGTCTCTTCAAGGGATTCAC, +
Primer MPV-CR GTTCTGCAGCTTCTTTTTCTTC, )
Primer MPV-Fc TCATATAAGCATGCTATATTAAAAGAGTCTCA, +
Primer MPV-Rc CCTATYTCTGCAGCATATTTGTAATCAG, )
Probe MPV-A FAM-ACAACAACTGCAGTGACACCCTCATCATT-BHQ, +
Probe MPV-B FAM-ACCACAACTGCAGTGACACCTTCATCATT-BHQ, +
a+, sense; ), anti-sense.
bT3 RNA polymerase promoter sequence AATTAACCCTCACTAAAGGGAGA before viral sequence.
cAdapted and modiﬁed from Maertzdorf et al. (2004).
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Precision study
A precision study was performed using dilution series of the
in vitro transcribed RNAs corresponding to 1 · 102, 1 · 103,
1 · 106 and 1 · 108 RNA transcripts per RT-PCR reaction.
For intra-assay variability, ﬁve parallel reactions were run on
one plate, whereas interassay variability was assessed by run-
ning one dilution series on four consecutive days.
DFA
Cells of the clinical samples were concentrated by centrifuga-
tion, placed on two slides, dried and ﬁxed in acetone. One
slide was tested for adenovirus, inﬂuenza A and B viruses,
hRSV and parainﬂuenza viruses 1–3 as primarily requested,
using the Light Diagnostics Respiratory DFA Viral Screen-
ing & Identiﬁcation Kit (Millipore, Billerica, MA, USA). The
other slide was stored at )70C and tested later for the
presence of hMPV antigen using four antibodies: Anti-human
Metapneumovirus (hMPV) (Argene, Verniolle, France), D3
DFA Metapneumovirus Identiﬁcation Kit (Diagnostic Hybrids,
Inc., Athens, OH, USA), OXOID hMPV (Imagen; Oxoid
Ltd, Cambridge, UK) and Human Metapneumovirus (hMPV)
DFA Reagent (Light Diagnostics; Chemicon International
Inc., Temecula, CA, USA).
Results
Detection limit and precision of the real-time RT-PCR
For the separate RT-PCR reactions, a detection limit of 50
RNA transcripts of hRSV per RT-PCR reaction was achieved
in repeated experiments. For hMPV subtypes A and B, a sen-
sitivity of 50 and 150 RNA transcripts was obtained, respec-
tively. Combining the separate RT-PCR assays as a duplex
RT-PCR resulted in decreased sensitivity and repeated detec-
tion of 100 RNA transcripts per reaction, corresponding to
103 copies/mL of sample, for hRSV was achieved. For hMPV
subtype A and B viruses, 100 and 1000 RNA transcripts,
equalling 103 and 104 copies/mL of specimen, respectively,
were detected.
In the precision study, intra-assay coefﬁcients of variation
of the cycle threshold (Ct) values for hRSV and hMPV sub-
type A and B viruses were 3.63%, 3.99% and 3.99%, and
interassay coefﬁcients of 3.78%, 5.59% and 5.80% were
obtained, respectively.
DFA
All four commercial antibodies showed a clear positive signal
for hMPV subtypes A1, A2, B1 and B2 on control slides of
the D3 DFA Metapneumovirus Identiﬁcation Kit, and no non-
speciﬁc staining was detected on negative control slides.
However, when 56 NPA samples were studied, two of the
antibodies, Anti-human Metapneumovirus (Argene) and
OXOID hMPV (Imagen), gave nonspeciﬁc signals in 27 and
seven samples, respectively. These nonspeciﬁc signals were
seen in samples positive for RSV, PIV2, InfA, InfB and adeno-
virus by DFA, but also in samples negative by DFA and nega-
tive for hMPV and hRSV in the RT-PCR assay. The remaining
294 samples were screened with the two hMPV antibodies
from Diagnostic Hybrids, Inc., and Light Diagnostics. These
reagents performed with equal sensitivity and speciﬁcity.
Patient samples
Of the 350 clinical specimens analyzed, 54 (15.4 %) and 4
(1.1 %) were found to be positive for hRSV and hMPV in
RT-PCR, respectively (Table 2). The age range of the hRSV
positive patients was from 1 month to 80 years (age median
2 years); 30 of the samples (55.6 %) were from children
under the age of 3 years and ten (18.5%) were from patients
over 18 years of age. Forty-one of the RT-PCR-positive sam-
ples and two of the RT-PCR-negative samples were positive
by DFA. Of the four specimens positive for hMPV by RT-
PCR, DFA was clearly positive for two samples and negative
for one (Table 2). The other RT-PCR positive sample was
considered DFA-negative for hMPV with discrepant DFA
staining for all four reagents used; hRSV RNA was detected
in this sample, whereas the DFA result for hRSV was
negative.
The age range of the hMPV positive patients was from
3 months to 44 years, with half of the patients being under
the age of 3 years and the other half being over 20 years of
age. Monthly proportions of RT-PCR-positive samples are
shown in Fig. 1.
TABLE 2. Results of the analysis of the clinical samples
Duplex RT-PCR
Immunoﬂuorescence
staining
Result
Number of
samples Result
Number of
samples
Negative 293 Negative 266
Adenovirus 6
Inﬂuenza A virus 3
Inﬂuenza B virus 3
Inﬂuenza A and hRSV 1
RSV 1
PIV1 2
PIV2 6
PIV3 2
Cell free sample 3
hRSV 53 Negative 12
hRSV 41
hMPV 3 Negative 1
hMPV 2
hRSV, hMPV 1 Negativea 1
aDiscrepant staining with the direct ﬂuorescent assay reagents used.
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Quality control samples
Analysis of the quality control samples found 11 and 12 sam-
ples positive for hMPV and hRSV, respectively, with one of
the samples being positive for both viruses. Two of the qual-
ity control specimens appeared negative. The results
obtained were consistent with the preference assay results
of the ﬁnal reports by the organizer and both A and B sub-
types of hMPV and hRSV were detected at all provided dilu-
tions. All samples of the adenovirus and enterovirus
programmes were negative in the RT-PCR assay.
Discussion
Identiﬁcation of hRSV and hMPV relies on the detection of
viral antigens and viral nucleic acids in clinical samples. The
use of RT-PCR for the detection of hRSV and hMPV has
been described in several studies and has been found to have
greater sensitivity than DFA and viral culture
[6,7,10,11,19,20]. However, DFA offers a rapid and simple
alternative to molecular assays, thus enabling rapid diagnosis.
Therefore, a combination of the two methods, with DFA as
a ﬁrst line test followed by RT-PCR for DFA-negative sam-
ples, may be the best approach for achieving rapid and sensi-
tive detection of hMPV and hRSV [21].
PCR-based tests enabling the detection of a large panel of
respiratory viruses from clinical samples are commercially
available. However, it is rarely necessary to simultaneously
test for all respiratory viruses, but rather tests are chosen to
test for the prevalent viruses compatible with the clinical pic-
ture of the patient. To simultaneously detect hRSV and
hMPV, viruses causing clinically indistinguishable illnesses, par-
ticularly in small children, we designed two primer pairs from
the nucleoprotein genes of these viruses because this gen-
ome region has been reported to facilitate the sensitive
detection of hMPV [12,22]. Because the routine diagnostics
of respiratory viruses in our laboratory is largely based on
DFA detection of viral antigens, we also compared the RT-
PCR results with commercially available antibodies for hMPV
detection.
The sensitivity of the duplex RT-PCR assay was 103 cop-
ies/mL of sample for hRSV and subtype A hMPV and
104 copies/mL for subtype B hMPV, which are values similar
to those obtained in other studies [23,24]. This is satisfac-
tory for clinical diagnosis because these viruses are usually
abundant in nasopharyngeal samples. It has been reported
that multiplexing often results in decreased sensitivity of
PCR and the detection limits of a multiplex RT-PCR for dif-
ferent viruses may differ notably [24]. In our assay, the
higher detection limit for type B hMPV may result from the
internal structures of the RNA transcript and from a single
mismatch generated in the production of the viral RNA tran-
script of virus strain NL/1/99 at the binding site of the pri-
mer MPV-F. Therefore, the actual sensitivity for subtype B
hMPV may be <104 copies/mL. The real-time RT-PCR assay
detected both hMPV and hRSV in one clinical sample and in
one quality control sample. This implies the ability to detect
co-infections of these viruses, although the effect of co-infec-
tion on sensitivity and precision of the assay was not studied.
The assay proved to have a high speciﬁcity for identifying all
positive quality control samples containing varying dilutions
of hMPV and hRSV subtypes A and B, and negative control
specimens, including those of the adenovirus and enterovirus
programmes, were negative. Furthermore, the 24 clinical
samples that were positive for other respiratory pathogens
by DFA were negative in RT-PCR for hMPV and hRSV
(Table 2), demonstrating the speciﬁcity of the RT-PCR assay.
Of the 350 clinical samples analyzed in the present study,
43 (12.3%) were positive for hRSV using the routine hRSV
antigen test and the real-time RT-PCR detected the virus in
an additional 13 specimens (3.7%). Two samples negative for
hRSV by RT-PCR were positive by DFA. It is not known
whether these results are the result of nonspeciﬁc staining in
DFA or false RT-PCR-negatives resulting from degradation
of viral RNA, inhibitors of ampliﬁcation or primer mis-
matches. Of the samples analyzed, two were considered
positive for hMPV by DFA and an additional two were posi-
tive in RT-PCR. Although the relatively high proportion of
positive results in adults obtained in the present study pro-
vides further evidence that hMPV and hRSV are respiratory
pathogens of adults, it also reﬂects the study samples, of
which only 42.3% were from small children who are the
most susceptible to these viruses. Our material included
samples from immunocompromised adults and children, and
it is well documented that both hRSV and hMPV are impor-
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FIG. 1. Monthly distribution of RT-PCR positive samples over the
course of the present study. hRSV, human respiratory syncytial virus;
hMPV, human metapneumovirus.
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tant pathogens among these patients [25]. Three of the four
hMPV positive patients were diagnosed with an underlying
haematological malignancy and one of these patients, a 2-
year-old girl, died 1 month later with unresolved lung tissue
damage seen at post mortem. Two adult haematological
patients and an otherwise healthy 3-month-old boy recov-
ered from the infection and had no subsequent documented
respiratory episode. Although the low number of hMPV posi-
tive specimens may reﬂect a low incidence of hMPV in clini-
cal disease, the current opinion is that asymptomatic carriage
of the virus is uncommon and the presence of hMPV RNA in
respiratory samples is associated with clinical infection
[2,6,17,21].
The reported incidence of hMPV and hRSV ranges
widely, from 1% to 31% and 4% to 41%, respectively, in dif-
ferent study populations [2,3,7,13,17,26,27]. The highest
detection rates are generally obtained in studies of inpa-
tients and pediatric patients, during high prevalence months
and in specimens negative for other respiratory viruses.
The incidence rate of 15.4% for hRSV in our study popula-
tion is in agreement with previously documented data,
although the 1.1% incidence rate of hMPV is low consider-
ing the samples were collected during high prevalence
months. However, the prevalence of hMPV is known to
vary from year to year and the study priod November
2007 to June 2008 may have represented a mild winter
[3,4,14,16,28]. Nevertheless, the results obtained in the
present study are consistent with another Finnish study
reporting an incidence rate of 1.3% in children [17] as well
as with previous studies reporting a greater abundance of
hRSV compared to hMPV [2,3,10,14,26], although a higher
prevalence of hMPV has also been reported [24]. In the
present study, hMPV infections occurred in February and
March 2008, whereas hRSV infections were found from
December 2007 to April 2008 (Fig. 1). Although this was
not an epidemiological study, these ﬁndings are in agree-
ment with reports on hMPV prevalence peaking later in the
year than hRSV infections [3,15,16]. Although dual infec-
tions with hMPV and hRSV and co-infections with other
respiratory viruses are commonly reported in clinical stud-
ies [4,14,18,27,29–31], we found only one co-infection of
hMPV and hRSV.
In conclusion, the real-time RT-PCR assay described in
the present study meets the current need for the rapid and
sensitive detection of hRSV and hMPV in cases of severe
respiratory diseases of unknown aetiology. The results
obtained in our study suggest that hMPV has a relatively
small role as a causative agent of respiratory illness com-
pared to hRSV but testing pediatric and immunocompro-
mised patients with respiratory symptoms for the presence
of hMPV seems justiﬁed. The simultaneous detection of
hRSV and hMPV will facilitate studies on the clinical presen-
tation of these viruses, including cases of co-infection.
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